NCT00150709View on ClinicalTrials.gov

A Study Of The Safety And Efficacy Of Levetiracetam (Keppra®) (Ucb L059) In Children With Epilepsy

PHASE3CompletedINTERVENTIONAL
Enrollment

223

Participants

Timeline

Start Date

January 26, 1998

Primary Completion Date

January 25, 2006

Study Completion Date

January 25, 2006

Conditions
Epilepsy, Partial
Interventions
DRUG

Levetiracetam

"* Pharmaceutical form: Oral tablets and oral solution~* Route of administration: Oral use"

Sponsors

Lead Sponsor

UCB Pharma
All Listed Sponsors
lead

UCB Pharma

INDUSTRY